R3VIVE vs 986 Pharmacy
Franchise Comparison 2026
Both R3VIVE and 986 Pharmacy are healthcare franchises. R3VIVE requires an investment of $262K – $669K while 986 Pharmacy requires $280K – $671K. Neither R3VIVE nor 986 Pharmacy makes a financial performance representation in Item 19 of its FDD — a voluntary item under the FTC Franchise Rule — so the two cannot be compared on disclosed unit revenue. FranchiseVerdict rates R3VIVE B (Above average) and 986 Pharmacy B (Above average).
| Metric | R3VIVE | 986 Pharmacy |
|---|---|---|
| Verdict Grade | BAbove average | BAbove average |
| Investment Range | $262K – $669K | $280K – $671K |
| Franchise Fee | $75K | $75K |
| Royalty Rate | 6.0% | Continuing License Fee: $1,575/month for first 12 months, then $2,100/month for remainder of term (Item 6 lists $1,650 for first 21 days then $2,100; footnote 2 states $1,575 for first 12 months then $2,100). May increase up to 5% annually. No percentage-of-sales royalty. |
| Average Revenue (Item 19) | N/ANo Item 19 representation | N/ANo Item 19 representation |
| SBA Charge-Off Rate | N/A | Limited data |
| Total Units | 10 | 44 |
| Unit Growth (YoY) | +2 units | +14 units |
| Year Began Franchising | 2020 | 2018 |
| FDD Year | 2022 | 2025 |
Investment Range
$262K – $669K
$280K – $671K
Franchise Fee
$75K
$75K
Royalty Rate
6.0%
Continuing License Fee: $1,575/month for first 12 months, then $2,100/month for remainder of term (Item 6 lists $1,650 for first 21 days then $2,100; footnote 2 states $1,575 for first 12 months then $2,100). May increase up to 5% annually. No percentage-of-sales royalty.
Average Revenue (Item 19)
N/ANo Item 19 representation
N/ANo Item 19 representation
SBA Charge-Off Rate
N/A
Limited data
Total Units
10
44
Unit Growth (YoY)
+2 units
+14 units
Year Began Franchising
2020
2018
FDD Year
2022
2025